다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Vertex Pharmaceuticals Inc (VRTX)
Vertex Pharmaceuticals Inc (VRTX) 뉴스

VRTX

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VRTX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/07/31	04:25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/31	02:10	Business Wire	Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/26	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/25	05:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/25	01:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/23	02:16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/18	05:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/15	22:00	PR Newswire (Canada)	Santé Canada autorise la commercialisation de TRIKAFTA(MD) (éléxacaftor/tézacaftor/ivacaftor et ivacaftor) chez les personnes atteintes de fibrose kystique âgées de 2 ans et plus présentant certaines mutations rares	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/15	22:00	PR Newswire (Canada)	Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare Mutations	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/13	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/10	23:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/02	21:33	Business Wire	Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/07/02	05:05	Business Wire	Vertex to Announce Second Quarter 2024 Financial Results on August 1	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/22	04:45	Business Wire	Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/20	20:15	Business Wire	Vertex Announces Extended Long-Term Reimbursement Agreement with NHS England for Access to Cystic Fibrosis Medicines KAFTRIO®, SYMKEVI® and ORKAMBI®	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/14	16:03	Business Wire	Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/14	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/14	05:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/12	22:56	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/12	22:54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/08	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/08	01:00	Business Wire	Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/06	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/06	05:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/04	22:10	IH Market News	Economic Worries May Lead To Weakness On Wall Street	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/04	05:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/04	02:56	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/04	02:38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/06/01	05:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc
2024/05/31	23:50	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VRTX	Vertex Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VRTX

1 2 3 4 5 6 7 8 9 10 다음 >>

Gold vs US Dollar

BNP Paribas (QX)

Financial Select Sector

Bank of America

Deutsche Telekom (QX)

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관